The estimated Net Worth of Bryan E Roberts is at least $297 Million dollars as of 20 May 2020. Bryan Roberts owns over 3,100,000 units of 10x Genomics stock worth over $28,460,933 and over the last 14 years he sold TXG stock worth over $267,969,225. In addition, he makes $787,863 as Independent Director at 10x Genomics.
Bryan has made over 13 trades of the 10x Genomics stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 3,100,000 units of TXG stock worth $241,800,000 on 20 May 2020.
The largest trade he's ever made was selling 3,100,000 units of 10x Genomics stock on 20 May 2020 worth over $241,800,000. On average, Bryan trades about 96,655 units every 34 days since 2010. As of 20 May 2020 he still owns at least 1,287,825 units of 10x Genomics stock.
You can see the complete history of Bryan Roberts stock trades at the bottom of the page.
Dr. Bryan E. Roberts Ph.D. serves as Independent Director of the Company. He has served on our board of directors since November 2013. Dr. Roberts joined Venrock, a venture capital firm, in 1997, where he currently serves as a Partner. Dr. Roberts currently serves as the Chairman of the board of directors of Castlight Health, which he co-founded, as well as a director on the boards of several private companies. Dr. Roberts previously served on the board of directors of athenahealth from 1999 to 2009, XenoPort from 2000 to 2007, Sirna Therapeutics from 2003 to 2007, Vitae Pharmaceuticals from 2001 to 2016, Zeltiq Aesthetics from 2008 to 2016, Ironwood Pharmaceuticals from 2001 to 2016, Hua Medicine from 2010 to 2018 and Achaogen from 2004 to 2019. From 1989 to 1992, Dr. Roberts worked in the corporate finance department of Kidder, Peabody & Co., a brokerage company. Dr. Roberts received a B.A. in Chemistry from Dartmouth College and a Ph.D. in Chemistry and Chemical Biology from Harvard University.
As the Independent Director of 10x Genomics, the total compensation of Bryan Roberts at 10x Genomics is $787,863. There are 5 executives at 10x Genomics getting paid more, with Serge Saxonov having the highest compensation of $2,362,960.
Bryan's mailing address filed with the SEC is C/O 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588.
Over the last 5 years, insiders at 10x Genomics have traded over $629,686,183 worth of 10x Genomics stock and bought 487,816 units worth $19,025,295 . The most active insiders traders include Bryan E Roberts, Capital Management I, Llc F..., and Benjamin J. Hindson. On average, 10x Genomics executives and independent directors trade stock every 8 days with the average trade being worth of $1,002,346. The most recent stock trade was executed by Serge Saxonov on 22 August 2024, trading 6,749 units of TXG stock currently worth $152,055.
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
10x Genomics executives and other stock owners filed with the SEC include: